Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients

Objective: Homeostasis of serum phosphorus and calcitriol level is regulated mainly by fibroblast growth factor 23 (FGF23). Studies show that elevated serum FGF23 level was significantly associated with aortic calcification severity, peripheral blood vessels, and a higher score of coronary artery ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Riri Andri Muzasti, Netty Delvrita Lubis
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Tzu Chi Medical Journal
Subjects:
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=2;spage=154;epage=159;aulast=Muzasti
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850259808148520960
author Riri Andri Muzasti
Netty Delvrita Lubis
author_facet Riri Andri Muzasti
Netty Delvrita Lubis
author_sort Riri Andri Muzasti
collection DOAJ
description Objective: Homeostasis of serum phosphorus and calcitriol level is regulated mainly by fibroblast growth factor 23 (FGF23). Studies show that elevated serum FGF23 level was significantly associated with aortic calcification severity, peripheral blood vessels, and a higher score of coronary artery calcification in patients undergoing hemodialysis. We did this cross-sectional study to determine the FGF23 diagnostic value for abdominal aortic calcification in Indonesian hemodialysis patients. Materials and Methods: This study included seventy-five, chronic hemodialysis patients. An enzyme-linked immunosorbent assay method was used to measure serum intact FGF23 level, and abdominal aortic calcification was detected by lateral lumbar X-ray. The diagnostic value of FGF23 was analyzed using receiver operating characteristic (ROC) curves. Results: fifty-one (68.0%) patients had abdominal aortic calcification (AAC). Serum intact FGF23 level ranged from 217 to 950 pg/mL with a median level of 328 pg/mL. The FGF23 levels in the serum of patients with AAC were significantly higher than those without AAC (P < 0.001). The best cutoff point was 277 pg/mL. The calculated area under the ROC curves was 0.959 (95% confidence interval, 0.912–1.00); sensitivity was 94.0% and specificity was 84.0% (P < 0.001). Conclusion: serum intact FGF23 level may be proposed as a proper tool for abdominal aortic calcification in Indonesian hemodialysis patients.
format Article
id doaj-art-dd1cbcf17fa94b51a9ddeeecf2d884bc
institution OA Journals
issn 1016-3190
2223-8956
language English
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Tzu Chi Medical Journal
spelling doaj-art-dd1cbcf17fa94b51a9ddeeecf2d884bc2025-08-20T01:55:46ZengWolters Kluwer Medknow PublicationsTzu Chi Medical Journal1016-31902223-89562021-01-0133215415910.4103/tcmj.tcmj_2_20Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patientsRiri Andri MuzastiNetty Delvrita LubisObjective: Homeostasis of serum phosphorus and calcitriol level is regulated mainly by fibroblast growth factor 23 (FGF23). Studies show that elevated serum FGF23 level was significantly associated with aortic calcification severity, peripheral blood vessels, and a higher score of coronary artery calcification in patients undergoing hemodialysis. We did this cross-sectional study to determine the FGF23 diagnostic value for abdominal aortic calcification in Indonesian hemodialysis patients. Materials and Methods: This study included seventy-five, chronic hemodialysis patients. An enzyme-linked immunosorbent assay method was used to measure serum intact FGF23 level, and abdominal aortic calcification was detected by lateral lumbar X-ray. The diagnostic value of FGF23 was analyzed using receiver operating characteristic (ROC) curves. Results: fifty-one (68.0%) patients had abdominal aortic calcification (AAC). Serum intact FGF23 level ranged from 217 to 950 pg/mL with a median level of 328 pg/mL. The FGF23 levels in the serum of patients with AAC were significantly higher than those without AAC (P < 0.001). The best cutoff point was 277 pg/mL. The calculated area under the ROC curves was 0.959 (95% confidence interval, 0.912–1.00); sensitivity was 94.0% and specificity was 84.0% (P < 0.001). Conclusion: serum intact FGF23 level may be proposed as a proper tool for abdominal aortic calcification in Indonesian hemodialysis patients.http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=2;spage=154;epage=159;aulast=Muzastiabdominal aortic calcificationfibroblast growth factor 23hemodialysis
spellingShingle Riri Andri Muzasti
Netty Delvrita Lubis
Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
Tzu Chi Medical Journal
abdominal aortic calcification
fibroblast growth factor 23
hemodialysis
title Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
title_full Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
title_fullStr Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
title_full_unstemmed Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
title_short Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
title_sort diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in indonesian hemodialysis patients
topic abdominal aortic calcification
fibroblast growth factor 23
hemodialysis
url http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=2;spage=154;epage=159;aulast=Muzasti
work_keys_str_mv AT ririandrimuzasti diagnosticvalueoffibroblastgrowthfactor23forabdominalaorticcalcificationinindonesianhemodialysispatients
AT nettydelvritalubis diagnosticvalueoffibroblastgrowthfactor23forabdominalaorticcalcificationinindonesianhemodialysispatients